ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ECOR vs OM // FREE CASH FLOW YIELD

electroCore Inc. (NASDAQ) VS. Outset Medical Inc. (NASDAQ) • 15-METRIC TALLY: ECOR 4 — OM 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ECOR VS. OM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ECOR OM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 86.80% 39.10% +47.70 ECOR /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -28.00% -7.00 OM /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -11.29% — — TIE /fcf-yield <GO>
Operating Margin -41.10% -55.80% +14.70 ECOR /operating-margins <GO>
Net Profit Margin -43.60% -60.00% +16.40 ECOR /net-margins <GO>
Revenue Growth (YoY) 27.20% 5.10% +22.10 ECOR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 6/9 -2.00 OM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 37.5 51.8 -14.25 OM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $73.1M $78.8M -$5.6M OM /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ECOR REV OM REV ECOR GROSS % OM GROSS % ECOR FCF OM FCF
FY 2025 $32.0M $119.5M 86.8% 39.1% -$8.3M -$47.1M
FY 2024 $25.2M $113.7M 85.0% 33.9% -$6.9M -$117.2M
FY 2023 $16.0M $130.4M — — -$14.7M -$131.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ECOR // BETA —
OM // BETA —